Neurotoxicity concern about the brain targeting delivery systems

Yubin Li,Jiajun Fan,Dianwen Ju

DOI: https://doi.org/10.1016/b978-0-12-814001-7.00015-9

2019-01-01

Abstract:Nanoparticles are the series of engineered structures whose diameter is less than 100nm and could be manufactured by numbers of different physicochemical processes depending on different types of properties and applications. The exclusive characteristics of these nanoparticles such as unique structures, monodispersity, high surface to mass ratio, and effective cellular property to uptake and absorb genes, proteins, or small molecular chemical drugs make them suitable for various applications in the fields of biomedicine. Owing to their unique properties, nanoparticles have the capacity to enter the central nervous system (CNS) by passing the blood-brain barrier (BBB). Since their toxicity, especially neurotoxicity triggered by nanoparticles, has become serious challenge during brain-targeted drug deliver, their related mechanisms of nanoparticles-triggered neurotoxicity have been investigated. This chapter introduces neurotoxicity concern about brain targeting drug delivery nanoparticles. It starts by presenting general neurotoxicity of the brain targeting drug delivery nanoparticles (metallic nanoparticles (silver, gold); metallic oxide nanoparticles (titanium dioxide; iron oxide); nonmetallic nanoparticles (silica, carbon); and polymers) in vitro (neurons; astrocytes; microglia; and other neuronal cells;) and in vivo; then it explains the related mechanisms of the brain targeting drug delivery nanoparticles-induced neurotoxicity, including physical mechanisms, cellular mechanisms, and molecular mechanisms. The physical mechanisms mainly include size, shape, and surface charge of nanoparticles; cellular mechanisms primarily focus on apoptosis, necrosis, autophagy, neutrophil extracellular traps (NETs)-mediated NETosis, pyroptosis, and cell cycle arrest; while molecular mechanisms are mainly involving reactive oxygen species, DNA damage, and signaling pathways. The related signaling pathways mainly focus on NF-kB, PI3K/Akt/mTOR, MAPK, and TGF-beta signaling pathway. The last part of the chapter discusses current perspective to solve brain targeting delivery nanoparticles-induced neurotoxicity. The chapter highlighted nanoparticles-triggered neurotoxicity and its related physicochemical and biochemical mechanisms, which might be useful for evaluating neurotoxicity of drug delivery nanoparticles and developing new biosafety brain-targeted drug delivery systems in the future.